Antibe Therapeutics Stock Market Value
| ATBPF Stock | USD 0.22 0.00 0.00% |
| Symbol | Antibe |
Antibe Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Antibe Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Antibe Therapeutics.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in Antibe Therapeutics on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Antibe Therapeutics or generate 0.0% return on investment in Antibe Therapeutics over 30 days. Antibe Therapeutics is related to or competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, Anebulo Pharmaceuticals, Rezolute, and HCW Biologics. Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the a... More
Antibe Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Antibe Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Antibe Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Antibe Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Antibe Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Antibe Therapeutics' standard deviation. In reality, there are many statistical measures that can use Antibe Therapeutics historical prices to predict the future Antibe Therapeutics' volatility.Antibe Therapeutics Backtested Returns
We have found three technical indicators for Antibe Therapeutics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Antibe Therapeutics are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Antibe Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Antibe Therapeutics time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Antibe Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Antibe Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Antibe Therapeutics lagged returns against current returns
Autocorrelation, which is Antibe Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Antibe Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Antibe Therapeutics returns to help us make a trade decision. For example, suppose you find that Antibe Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Antibe Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Antibe Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Antibe Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Antibe Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Antibe Therapeutics Lagged Returns
When evaluating Antibe Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Antibe Therapeutics pink sheet have on its future price. Antibe Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Antibe Therapeutics autocorrelation shows the relationship between Antibe Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Antibe Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Antibe Pink Sheet
Antibe Therapeutics financial ratios help investors to determine whether Antibe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Antibe with respect to the benefits of owning Antibe Therapeutics security.